Summit Therapeutics (SMMT) Q1 2023 Earnings

11MayConfirmed
Aug 22
Nov 22
Q4 2022
Q1 2023
-1.43
-0.98
-0.52
-0.07

Details

Expected EPS
N/A
Actual EPS
-1.43
Surprise EPS
-1.43
Surprise Percent
+∞%

Description

Summit Therapeutics (SMMT) has reported earnings of -1.43 per share for Q1 2023.

0 Comments

Share your thoughts